|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2010-3-10
|
|
pubmed:abstractText |
Bevirimat is the first drug of a new class of antivirals that hamper the maturation of HIV. The objective of this study was to evaluate the sequence variability of the gag region targeted by bevirimat in HIV subtype-B isolates.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1473-5571
|
|
pubmed:author |
pubmed-author:BellF AFA3rd,
pubmed-author:BrunenDiedeD,
pubmed-author:DauweKennyK,
pubmed-author:FelixA J WAJ,
pubmed-author:KaiserRolfR,
pubmed-author:NijhuisMoniqueM,
pubmed-author:PfisterHerbertH,
pubmed-author:VandekerckhoveLinosL,
pubmed-author:VerheyenJensJ,
pubmed-author:VerhofstedeChrisC,
pubmed-author:WensingAnnemarie M JAM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
13
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
669-73
|
|
pubmed:meshHeading |
pubmed-meshheading:19926962-Drug Resistance, Viral,
pubmed-meshheading:19926962-Genotype,
pubmed-meshheading:19926962-HIV Infections,
pubmed-meshheading:19926962-HIV Protease Inhibitors,
pubmed-meshheading:19926962-HIV-1,
pubmed-meshheading:19926962-Humans,
pubmed-meshheading:19926962-Molecular Sequence Data,
pubmed-meshheading:19926962-Mutation,
pubmed-meshheading:19926962-Prevalence,
pubmed-meshheading:19926962-Sequence Analysis, DNA,
pubmed-meshheading:19926962-Succinates,
pubmed-meshheading:19926962-Triterpenes,
pubmed-meshheading:19926962-gag Gene Products, Human Immunodeficiency Virus
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
High prevalence of bevirimat resistance mutations in protease inhibitor-resistant HIV isolates.
|
|
pubmed:affiliation |
Institute of Virology, University of Cologne, Cologne, Germany. jens.verheyen@uk-koeln.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
